TIS 0.00% 0.0¢ tissue therapies limited

Ann: VitroGro Sales Planned to Start in June 2012, page-55

  1. 492 Posts.
    re: Ann: VitroGro Sales Planned to Start in J... Paradigmshift

    "discussions with management also indicate that revenues will be used to fund FDA costs so no costly dilution at this share price"

    Were these personnel discussions? Information derived from a research report? Or another information source?

    In my mind the US trial is one of two potential capital raising catalysts.

 
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.